State Street’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-594,555
| Closed | -$5.93M | – | 4334 |
|
|
2025
Q2 | $5.93M | Buy |
594,555
+12,558
| +2% | +$101K | ﹤0.01% | 2857 |
|
|
2025
Q1 | $3.47M | Sell |
581,997
-3,939
| -0.7% | -$28.9K | ﹤0.01% | 3030 |
|
|
2024
Q4 | $4.5M | Sell |
585,936
-589,417
| -50% | -$5.06M | ﹤0.01% | 3021 |
|
|
2024
Q3 | $12M | Buy |
1,175,353
+211,452
| +22% | +$3.23M | ﹤0.01% | 2500 |
|
|
2024
Q2 | $14.3M | Buy |
963,901
+386,356
| +67% | +$5.54M | ﹤0.01% | 2342 |
|
|
2024
Q1 | $7.88M | Buy |
577,545
+25,990
| +5% | +$283K | ﹤0.01% | 2716 |
|
|
2023
Q4 | $6.04M | Sell |
551,555
-1,029,938
| -65% | -$10.2M | ﹤0.01% | 2859 |
|
|
2023
Q3 | $17.3M | Buy |
1,581,493
+16,291
| +1% | +$208K | ﹤0.01% | 2249 |
|
|
2023
Q2 | $20.7M | Sell |
1,565,202
-262,189
| -14% | -$3.74M | ﹤0.01% | 2229 |
|
|
2023
Q1 | $24.9M | Buy |
1,827,391
+90,101
| +5% | +$1.61M | ﹤0.01% | 2081 |
|
|
2022
Q4 | $33.9M | Sell |
1,737,290
-370,578
| -18% | -$7.24M | ﹤0.01% | 1894 |
|
|
2022
Q3 | $40.2M | Sell |
2,107,868
-370,464
| -15% | -$8.53M | ﹤0.01% | 1757 |
|
|
2022
Q2 | $51.1M | Buy |
2,478,332
+766,441
| +45% | +$18.2M | ﹤0.01% | 1620 |
|
|
2022
Q1 | $55.1M | Buy |
1,711,891
+948,540
| +124% | +$34.5M | ﹤0.01% | 1692 |
|
|
2021
Q4 | $35.5M | Buy |
763,351
+441,244
| +137% | +$14.7M | ﹤0.01% | 2057 |
|
|
2021
Q3 | $8.7M | Buy |
322,107
+3,938
| +1% | +$103K | ﹤0.01% | 2963 |
|
|
2021
Q2 | $8.16M | Sell |
318,169
-384,841
| -55% | -$9.17M | ﹤0.01% | 3016 |
|
|
2021
Q1 | $24M | Buy |
703,010
+514,008
| +272% | +$18.6M | ﹤0.01% | 2250 |
|
|
2020
Q4 | $6.39M | Buy |
189,002
+57,773
| +44% | +$1.53M | ﹤0.01% | 2845 |
|
|
2020
Q3 | $3.24M | Buy |
+131,229
| New | +$3.53M | ﹤0.01% | 3002 |
|
Other funds holding ITOS
State Street's ITOS Position: Q3 2025 in Review
State Street sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 594,555 shares — an estimated $5.93M sold.
State Street first reported a position in ITOS in Q3 2020 and held it in 20 quarters. The position peaked at $55.1M in Q1 2022. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.
- State Street reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
- State Street sold 594,555 iTeos Therapeutics shares in Q3 2025, an estimated $5.93M.
- State Street first reported a position in iTeos Therapeutics in Q3 2020 and held it in 20 quarters.
- State Street's iTeos Therapeutics position peaked at $55.1M in Q1 2022.
- 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.
Based on State Street's 13F filing for Q3 2025, filed 14 Nov 2025.